Capstone Investment Advisors
TARO

Capstone Investment Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Capstone Investment Advisors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,900
Closed -$303K – 573
2017
Q4 		$303K Buy
+2,900
New +$319K 0.01% 362
2016
Q4 		– Sell
-5,168
Closed -$571K – 1147
2016
Q3 		$571K Sell
5,168
-3,633
-41% -$481K 0.01% 494
2016
Q2 		$1.28M Buy
+8,801
New +$1.25M 0.02% 307

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
FL
Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capstone Investment Advisors's TARO Position: Q1 2018 in Review

Capstone Investment Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2018, closing a stake of 2,900 shares — an estimated $303K sold.

Capstone Investment Advisors first reported a position in TARO in Q2 2016 and held it in 3 quarters. The position peaked at $1.28M in Q2 2016. 109 funds tracked by Wall St. Rank hold TARO as of Q1 2018.

  • Capstone Investment Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2018 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,900 Taro Pharmaceutical Industries Ltd. shares in Q1 2018, an estimated $303K.
  • Capstone Investment Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 3 quarters.
  • Capstone Investment Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $1.28M in Q2 2016.
  • 109 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2018.

Based on Capstone Investment Advisors's 13F filing for Q1 2018, filed 15 May 2018.